Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment ImprovementY. Kogan, B. Ribba, K. Marron, N. Dahan, V. Vainstein and Z. AgurMath. Model. Nat. Phenom., 2 3 (2007) 47-68DOI: https://doi.org/10.1051/mmnp:2007003
